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Abstract
Background: In Nigeria ACT use at the community level has not been evaluated and the use of
antimalarial drugs (commonly chloroquine (CQ)) at home has been shown to be largely incorrect.
The treatment regimen of ACT is however more complicated than that of CQ. There is thus a
need to determine the feasibility of using ACT at the home level and determine community
perception on its use.
Methods: A before and after qualitative study using key informant interviews (KII) and focus group
discussions (FGDs) was conducted in selected villages in Ona-Ara local government area. At
baseline, 14 FGDs and 14 KIIs were conducted. Thereafter, community medicine distributors
(CMDs) were trained in each village to dispense artemeter-lumenfantrine (AL) to febrile children
aged 6–59 months presumed to have uncomplicated malaria. After one year of drug distribution,
nine KIIs and 10 FGDs were conducted. Participants and key informants were mothers and fathers
with children under five years, traditional heads of communities, opinion leaders and health
workers.
Results: None of the participants have heard of AL prior to study. Participants were favourably
disposed to introduction of AL into the community. Mothers/caregivers were said to have used AL
in place of the orthodox drugs and herbs reported commonly used prior to study after
commencement of AL distribution. The use of CMDs for drug distribution was acceptable to the
participants and they were judged to be efficient as they were readily available, distributed correct
dose of AL and mobilised the community effectively. AL was perceived to be very effective and no
significant adverse event was reported. Major concerns to the sustainability of the program were
the negative attitudes of health workers towards discharge of their duties, support to the CMDs
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and the need to provide CMDs incentives. In addition regular supply of drugs and adequate
supervision of CMDs were advised.
Conclusion: Our findings showed that the use of AL at home and community level is feasible with
adequate training of community medicine distributors and caregivers. Community members
perceived AL to be effective thus fostering acceptability. The negative attitudes of the health
workers and issue of incentives to CMDs need to be addressed for successful scaling-up of ACT
use at community level.
Background
In Nigeria, malaria accounts for 25% of infant mortality
and represents 8–12% of deaths in children less than 5
years [1]. The infection is commonly managed at home
using orthodox and herbal medicines. When orthodox
treatments are given at home, dosages are often incorrect
and inadequate [2-4]. This may have contributed to the
emergence of parasites resistant to the hitherto effective
and cheap antimalarial drugs such as chloroquine and
more recently sulphadoxine-pyrimethamine [5-8]
In an effort to stem the worsening morbidity and mortal-
ity due to drug resistant malaria, Nigeria changed its
malaria treatment policy from chloroquine (CQ) or sulf-
adoxine-pyrimethamine (SP) to artemisinin based combi-
nation therapy (ACT) in line with the WHO
recommendation [9], with a preference for artemether-
lumefantrine (AL) in January 2005 [8]. In addition to the
change of drug of first choice, the Federal Ministry of
Health (FMOH) proposes to deploy ACT at community
level in the context of home management of malaria
(HMM). The dosage regimen for AL is however more com-
plicated than that of CQ or SP. This underscores the need
to determine the feasibility of using AL at the community
level, ensuring adherence to dose regimen. In addition,
there is a need to explore from the community perspective
the effectiveness and safety of the drug when dispensed by
non-medical personnel. Effort during this study was
directed at this important issue in order to safe-guard the
clinical useful life of this newer and effective antimalarial
drug combination.
Methods
Study site
This study was conducted in 40 communities in two rural
health districts selected by random sampling from the
eight health districts that make up Ona-Ara Local Govern-
ment area (LGA), in south western Nigeria from July 2005
to January 2007. A well established collaboration exists
between researchers in the College of Medicine, the State
Ministry of Health and the health unit of the Local Gov-
ernment (LG) having carried out studies on malaria in the
LGA in the past. At the time of commencing this study,
ACT has not been deployed to the LGA health facilities by
the Government and was not available in the private sec-
tor either. The study site has been described in detail by
Ajayi et al. 2008 [10].
Health services in Ona-ara Local Government Area
The health care system (HCS) in Nigeria consists of three
levels namely: primary, secondary and tertiary levels. The
Local Governments are generally responsible for primary
health care (PHC). In Ona-Ara LGA there is a Primary
Health Care (PHC) unit at the LG headquarters and the
coordinator of the unit is usually a medical doctor who
oversees the activities of the health facilities in the LGA.
Each of the health districts has a health centre and mater-
nity centre. The health centres are manned by a team of
community health workers headed by a registered nurse/
midwife. Few traditional healers and birth attendants
(TBAs) provide indigenous health care in the districts.
However, majority of the caregivers seek care from patent
medicine sellers (PMS) and itinerant drug hawkers [10].
The populations of the villages in the two districts vary
from 50 to 8,000 and are spread over a vast area with poor
transportation and road network; making it difficult for
the government health structures to be easily accessible or
effective.
Study design
This qualitative study is a component of a quasi-experi-
mental study to evaluate the feasibility, accessibility and
safety of using ACT for home management of malaria. To
conduct a situation analysis prior to distribution of AL for
HMM, Focus Group Discussions (FGDs) and Key Inform-
ant Interviews (KIIs) were viewed appropriate [11]. These
were used to explore caregivers' and community mem-
bers' opinions on malaria as it affects children, the prevail-
ing treatment seeking behaviour including practice of
home management of malaria and the potential for
change. The findings of the situation analysis were used in
the planning of the intervention including mechanism for
drug distribution. After one year of intervention during
which AL was distributed by selected and trained commu-
nity based medicine distributors (CMDs) in study com-
munities, the communities' perception on the use of AL
for HMM, strategies for its distribution and accessibility to
the people as well as acceptability were explored. In addi-
tion, household survey was conducted (to be reportedBMC Health Services Research 2008, 8:119 http://www.biomedcentral.com/1472-6963/8/119
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separately). CMDs in this study comprised patent medi-
cine sellers, health workers and mothers selected by the
communities to be trained as "mother trainers".
Sample population
Communities were selected for FGD and KII by random
sampling technique from the 40 communities at baseline
and after intervention respectively. The participants for
the FGD which comprise mothers and fathers were
selected using purposive sampling based on the recom-
mendation by village head or opinion leader who per-
ceived them to have sufficient knowledge and experience
on the issues to be addressed and would be able to discuss
freely [12]. In addition they must have a child less than
five years or must have taken care of a child in the past.
Focus group discussions (FGDs) were held in groups of six
to nine women or men. The key informants were purpo-
sively selected based on their position in the community,
their role in implementation, or because of the special
information they possessed based on their involvement in
the management of childhood fevers.
At baseline, a total of 14 FGDs comprising four groups of
young mothers [aged <35 years], old mothers [≥ 35 yrs],
and three groups each of young fathers [<35 years] and
Old fathers [≥ 35 years] were conducted. Fourteen KIIs
with six opinion/community leaders, four drug sellers and
four health workers were also conducted. Post interven-
tion, a total of 10 FGDs and nine KIIs were conducted.
Three groups of young mothers, three of old mothers, two
of young fathers and two groups of old fathers were
involved in the FGD while three patent medicine sellers
(PMS), four opinion/community leaders, and two health
workers were interviewed during the KIIs. The total num-
bers of participants at the FGD sessions at baseline and
post intervention were 103 and 89 respectively.
Conduct of qualitative study [FGD and KII]
The interviews were conducted by trained research assist-
ants. Two teams of three assistants (moderator, note
keeper and recorder) conducted the sessions. The teams
were supervised by the social scientist (BO) on the
research team. The research assistants had a 4-day training
prior to conduct of the study. Training included familiari-
zation with research tools and practicing interviews.
Research assistants were also taught basic techniques of
probing, recording responses, and note-taking as well as
transcription of recordings. Fundamentals of organizing
and conducting FGDs were also included in the training.
Field guides were developed and pre-tested prior to use.
The guides were translated into Yoruba – the local lan-
guage.
Participants at both the FGDs and KIIs were shown the
tape recorder and verbal informed consent to carry out the
exercise and to record the sessions and interviews was
obtained from each participant. The FGD sessions and KII
lasted between 40–80 minutes. Interviews and FGDs were
conducted to the point at which no new information was
forthcoming. The participants were given a pack contain-
ing multivitamins and acetaminophen (paracetamol) at
the end of each session. Transcription was completed
daily.
Intervention Activities
Selection of CMDs
Intensive advocacy and sensitization of community
heads, opinion leaders and residents of the selected com-
munities were carried out in the company of the LG PHC
unit coordinator and malaria control program officers.
The community heads were briefed about the purpose of
the study and method of collection of information. They
were requested to select mothers to be trained as "mother
trainers" from their communities. Selection criteria for
CMDs included being a permanent resident (at least one
year), trusted and respected by the community, able to
keep simple records, and a willingness to serve. In addi-
tion, the selected mothers should have the consent of
their husbands. Selected mothers and the existing patent
medicine sellers and itinerant drug hawkers were trained
and they served as community based medicine distribu-
tors.
Treatment guideline
A treatment guideline developed for a past study on HMM
using chloroquine [10] was adapted for ACT use in this
study and pre-tested prior to distribution to every house-
hold in the study communities by the CMDs. The guide-
line was in cartoon format and had pictorial illustrations
of some common clinical features of uncomplicated
malaria, the correct dose and regimen of AL according to
the age of the child [Fig 1]. Training was conducted for car-
egivers by the CMDs in their communities to improve
their ability to recognise uncomplicated and severe
malaria and on how to use the guideline.
Study Drug and distribution
The drug of choice for this study was AL (Coartem®;
Novartis) in line with the FMOH choice of ACT. The rec-
ommended dose for children aged six to 35 months was
one tablet twice daily for three days, and for children aged
36 to 59 months two tablets twice daily for three days.
Community medicine distributors (CMDs) were trained
to dispense AL to caregivers of febrile children aged 6–59
months presenting to them, after exclusion of danger
signs. They provided instructions on dose regimen, possi-
ble adverse event and danger signs. Caregivers were
advised to administer the drug with or after meals, prefer-
ably fatty food. The caregivers then administer the drug to
their children at home unsupervised. Direct observationBMC Health Services Research 2008, 8:119 http://www.biomedcentral.com/1472-6963/8/119
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Treatment Guideline depicting some symptoms of uncomplicated malaria and the dosage regimen for Coartem® Figure 1
Treatment Guideline depicting some symptoms of uncomplicated malaria and the dosage regimen for Coar-
tem®.BMC Health Services Research 2008, 8:119 http://www.biomedcentral.com/1472-6963/8/119
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or active follow-up of caregivers by CMDs was not recom-
mended. Monthly supervision was carried out by research
staff to check entries in CMDs record and drug stocks. The
supply of AL was from Global Fund to fight Malaria/TB/
HIV/AIDs and was distributed through the FMOH,
Nigeria. Drugs were provided through the existing health
centres in the districts. CMDs replenished their stock at
monthly meetings at the health facilities or as the need
arose. In some instances drugs were delivered by the
research staff during supervisory visits.
In the spirit of community participation and ownership,
the team and community decided that the drug should be
sold at an affordable price to the caregivers. At focus group
meetings with CMDs and community members prices
which ranged from 10.00 to 250.00 (8 cents to 2 USD)
were suggested to be charged for AL. However, 20.00 (16
cents) was mentioned to be the most affordable for car-
egivers. Thereafter, having made due consultation with
community heads and opinion leaders, it was agreed that
the 6 × 1 dose pack be sold for 30.00 (24 cents) and the 2
× 6 dose pack for 50.00 (40 cents). The team and CMDs
agreed that a commission of 30.00 (24 cents) on every
pack of AL sold should be given as incentive to cover the
profit the PMS would have made normally on selling
other antimalarial drugs as well as to compensate for the
time the CMDs were likely to spend attending to a febrile
child. However, this had to be revised at six months into
the distribution of AL in line with the FMOH policy that
it should be made free to children. The project had to take
up payment of the incentives as agreed upon in other to
motivate the CMDs and to ensure smooth continuation of
the study.
Analysis
All interviews were tape recorded and transcribed in
Yoruba the language which was used to conduct inter-
views and FGDs. Two of the research assistants and the
social scientist (BO) and one of the authors (IOA) listened
to the recordings, checked the accuracy of the transcripts
and translated the transcript from Yoruba to English. Con-
tent analysis was performed independently by two of the
authors IOA and BO the social scientist. They compared
notes for congruency and where there was incongruence
they re-read the transcript and made necessary corrections
From the transcripts and field notes, the responses from
different informants or groups (FGD) to questions asked
to explore issues of interest were grouped together, coded
and analyzed according to themes related to recognition
of malaria, treatment practices, use and adherence to use
of AL, adherence of CMDs, effectiveness and safety of AL,
drug distribution mechanism and sustainability of the
intervention. The findings were described, interpreted and
reported in form of narratives.
Ethics
Ethical approval for the study was provided at national
level by the Oyo State Ethical Review Board and the Ethics
Review Committee of the WHO. Informed consent was
obtained from community heads, household heads and
the caregivers who participated in the study.
Results
The results are presented in two parts. The first part is the
exploration of the knowledge of caregivers about malaria,
the prevailing treatment seeking behaviour in the commu-
nity prior to the intervention and the participants'
involvement in determining the intervention activities.
The second part reported findings at assessment of inter-
vention one year after distribution of AL.
Knowledge and Recognition of Malaria in Children
An important exploratory study was conducted at the
beginning of the FGDs to ascertain the study communi-
ties' definition and nomenclature for malaria. The locally
recognized syndromes in children treated with antimalar-
ial drugs by participants and the local terminology 'iba'
were explored. Most of the FGD participants described
"iba"- the local terminology for fever as high temperature
associated with chills/rigors, vomiting, anorexia, head-
ache and weakness. This definition is consistent with the
symptomatology of malaria as seen in clinical practice.
The FGD participants also mentioned that "iba" when lit-
erarily translated means fever, "iba" is as such also used for
other febrile illnesses not presumed to be malaria. How-
ever, if a febrile illness is perceived to be from another
cause the "iba" terminology is further qualified. Examples
given by FGD participants are: a febrile illness perceived to
be caused by measles, is called "iba ogbele". "Ogbele" is the
Yoruba word for measles and "iba typhoid" if the fever is
perceived to be due to typhoid fever. This preliminary
finding was useful in ensuring that researchers and com-
munity members were in agreement in the use of the ter-
minology for malaria.
Malaria in children was perceived to be a serious problem
in the community and the general consensus among the
participants was that it kills children fast if care is not
sought promptly. A young mother said: "malaria is a major
health problem because if it stays too long in a child's body, it
drains the blood".
The participants demonstrated good knowledge of the
symptoms and signs of malaria. The symptoms and signs
participants associated with uncomplicated malaria
included fever, chills, excessive weakness, anorexia, vom-
iting, excessive sleep, 'stretching of the body', concen-
trated urine, headache and dull looking eyes. For severe
malaria, they mentioned very high fever, convulsion/fits,
restlessness, prostration, excessive vomiting and weak-BMC Health Services Research 2008, 8:119 http://www.biomedcentral.com/1472-6963/8/119
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ness, yellow eyes and dark coloured urine. Some respond-
ents mentioned they suspect severe malaria when a febrile
child is not responding to the treatment first given.
Treatment practices
The prevailing treatment practice for malaria in children
at onset of this study was the use of orthodox drugs
bought from patent medicine sellers (PMS) or drug hawk-
ers and the use of local herbs at home. The option first
explored depended on availability. Commonly, herbs
were mentioned to be readily available hence are used first
in many instances. This is usually followed by orthodox
drugs if available soon after in addition to the herbs
already given. In situations that a caregiver has orthodox
drug at home this may be given first. Treatment was
reported to be instituted promptly mostly within 24 hrs of
noticing fever by all participants.
It is only when the herbs or drugs used are found not to
be effective that child is taken to the health care facility.
Referral often takes place after about 2–3 days of treat-
ment at home. During one of the FGDs a young mother
said: "the first thing we do is to prepare herbs for the child when
the body is hot and administer it before drug hawkers come
because they don't come regularly".
This was corroborated by health workers at KII. One
reported thus: "many of the parents first treat their children
with herbs. They may also buy drugs from patent medicine sell-
ers and combine with herbs. The reason why they buy drugs
from hawkers is that they think the method will work; they
come to the health centre when the illness is not responding to
the drugs already used".
FGD participants also mentioned that children consid-
ered to have severe malaria were usually first treated with
herbs and then taken to the health centre when there is no
improvement after administration of herbal preparations.
A young mother said: "we give herbs and use leaf and palm
oil or black soap to wash the child so that child will get better
before taking the child to anywhere (health facility or patent
medicine seller)".
The orthodox drugs commonly used in the home manage-
ment of malaria were chloroquine and paracetamol.
However, many mentioned that they lacked adequate
knowledge of the correct use of these drugs and relied on
drug sellers' instructions. The common sources of drugs in
the communities were itinerant drug hawkers and patent
medicine sellers who sometimes also hawk drugs. The
major barriers to accessing health facilities identified were
non-availability or erratic supply of drugs in the health
care facilities, distance of some of the communities to the
health centres, poor transportation system in the rural
areas and financial constraints on the part of the caregiv-
ers. Other barriers were related to the negative attitudinal
disposition of the health workers. These include absentee-
ism of health workers [HW] and unauthorized charges for
treatment, which may not be affordable. Reasons prof-
fered for HW misdemeanour include HWs' displeasure at
being posted to the rural area and problems with trans-
portation from the city [where most of them reside] to the
health centre in the rural area; while some participants
believed that some of the HWs were just out to make
money.
The estimated cost of treatment (based on caregivers'
judgment) for an episode of febrile illness in a child if
orthodox drugs were used ranged from 100.00 – 7000.00
[90 cents to 55 USD). The estimated cost for home man-
agement ranged from 100 – 500 [90 cents – 4 USD] while
treatment at health facilities was estimated at 500 – 2,
000.00 [4 USD – 17 USD] for out patient treatment and
2,000.00 – 7,000.00 [17 USD – 55 USD] if the child was
admitted for in-patient care. These estimated costs
included cost of the different types of drugs given and the
cost of transportation which ranged from 20.00 to 500
[16 cents – 4 USD] to travel to nearby or distant village or
to the city of Ibadan.
Awareness and willingness to use artemether-lumefantrine (AL)
None of the participants at FGD had heard of AL at base-
line. A few of the health workers mentioned they had
learned of government's intention to distribute the drug
but have not seen it before. All the participants were
favourably disposed to the introduction of AL for treat-
ment of malaria in their children provided it is an effective
drug. One young mother said:
"Since you say it is very effective, bring it for our children. We
will have peace of mind because the incidence of children fall-
ing sick often and often will be reduced".
The older mothers and fathers referred to the caretaker
role of the government. They mentioned that it is the
responsibility of the government to look after the health
of her people, as such; "it is a good idea, if the government
introduces it into the community".
Comprehension and Understanding of the Package of AL
In order to determine the FGD and KII participants'
understanding of the illustrations on the package of AL
and the appropriateness to the local setting, samples of
the AL (Fig 2) to be distributed were shown to the partici-
pants at baseline. Most of the participants recognized the
pack of AL as drug meant to be taken by children because
of the picture of a child on the pack. However, their expla-
nations on the use based on illustrations on the pack were
mostly incorrect. Some said it is for malaria because theBMC Health Services Research 2008, 8:119 http://www.biomedcentral.com/1472-6963/8/119
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colour of the tablet is yellow and because a mosquito
which was perceived to be a cause of malaria is drawn on
the pack. Many participants could not comprehend how
to administer the drug by just studying the drawing on the
pack. The responses are that one tablet of AL is to be used
three times a day for two days (1 × 6 pack); one daily for
six days (1 × 6 pack) or twelve days (2 × 6 pack) and that
the tablet is to be divided into two because each tablet has
a line down its middle.
They requested to be given verbal instruction and training
on how to use the drugs for better understanding and cor-
rect usage.
Opinion about drug distribution process
There were mixed opinions amongst participants regard-
ing the preferred outlet for the distribution of AL. The out-
lets mentioned were the existing health centres, drug
sellers (PMS and drug hawkers), trained mothers, com-
munity leaders and research team. The most mentioned
was through trained mothers. A few mentioned that drug
should be distributed to each household based on the
number of children therein. However, from the reasons
given for preferring one to the other, many of the respond-
ents raised objections to the use of drug sellers especially
drug hawkers followed by health workers. Only a few
raised objections to use of mothers while none raised
objection to the use of community leaders and research
team. The FGD participants were of the opinion that the
PMS and health workers will sell the drugs to them even if
meant to be distributed free or hike the price if they were
to be sold. The anxiety expressed by the mothers and car-
egivers stemmed from past experiences where by some
drug sellers and health workers had demanded money for
drugs that were meant to be free or hoard the drugs for
their own private use. Another concern expressed by the
mothers was the HWs irregular attendance at work.
Quotes to support these responses included:
"Yes, use mothers for the distribution of the drug in this com-
munity, don't use drug hawkers, because they may sell it and
people that cannot afford it will not be able to buy "- said a
young father.
A "traditional ruler" of one of the communities said: "Give
the drug to us, we will give it to the mothers and also give it to
health workers at the health centres to give to children that are
brought to the centre".
Assessment of intervention after one year of distributing 
AL
Awareness and use of AL
Most of the participants at FGDs held after one year of dis-
tributing AL mentioned that they have heard about AL. A
few participants in the FGD groups for fathers mentioned
Picture showing the packs of Coartem® Used [2 × 6 & 1 × 6] Figure 2
Picture showing the packs of Coartem® Used [2 × 6 & 1 × 6].BMC Health Services Research 2008, 8:119 http://www.biomedcentral.com/1472-6963/8/119
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that they have not heard about the drug. One quotation to
corroborate their awareness goes thus:
Yes, we have heard about the drug and have the treatment
guidelines. It is for treatment of malaria in children and it is
good" said a young mother. Participants also mentioned
that they used AL to treat their children during episodes of
febrile illness presumed to be malaria. This was supported
by this quotation:"since you introduced the drug into our
community, mothers go to the CMDs to collect drug for febrile
children presumed to have iba". Treatment was reported to
be instituted promptly mostly within 24 hrs of noticing
fever by all participants. A young father said:
"Mothers go to collect drugs from CMDs as soon as they notice
"iba" in a child. They use the drug quickly, because they know
if they delay, the illness may progress and prevent them from
going to their work".
Most of the participants mentioned that children suffering
from severe malaria are supposed to be taken to the hos-
pital/health centre as the first line of treatment. However,
few participants, mostly older mothers' and older fathers'
still mentioned herbs as first line treatment and would
only take such children to hospital if there was no
improvement. In one FGD group, a mother admitted that
she took her child to the health centre after tepid sponging
and putting a mouth gag (teaspoon wrapped with cloth)
when her child had symptoms suggestive of severe
malaria (very high fever, vomiting and convulsion/fits).
Most of the participants who had used AL mentioned they
were able to understand the dosing schedule after the
training by CMDs who also provided instructions at the
point of collection of the drug. The participants also men-
tioned that the guideline which was provided as hand
bills to the households aided their understanding of the
dosage regimen for AL. However, a few FGD participants
who were mainly fathers and "old mothers" mentioned
they did not understand the illustrations on the pack. All
the participants who had used AL mentioned that the cost
of treatment of a febrile child reduced drastically with the
distribution of AL. The cost was less than 50 cents (USD)
when AL was being sold. When it became free, the cost
incurred was mainly for other drugs such as paracetamol
and multivitamins when prescribed. There was no trans-
portation cost since drug was available within walking
distance.
Drug Distribution
At the end of the intervention, participants expressed sat-
isfaction with the idea of keeping drugs with people
within the community. They mentioned that PMS and
"mother trainers" were not far from them and were always
available when needed be it day or night.
One young man attested to the effectiveness of the
'mother trainer' in his community. He said: "The mother
trainer you selected in my community put a lot of effort to
ensure that people know about the drug and use it. She goes
around educating people, creating awareness and she is always
available. Please help to reward her".
None of the participants mentioned that any of the CMDs
charged illegal fees. Many of the young fathers mentioned
the drug was given to the caregivers free. During KII, opin-
ion leaders mentioned that they appreciated the wide dis-
tribution and availability of the drugs within the
community. They also mentioned that people in the
neighbouring communities took advantage of the facility
and that drugs were always available unless the CMD was
out of stock. A young mother said: CMDs are always avail-
able. It is good we have two in our community, when one is out
of the village the other one attends to caregivers. One partici-
pant expressed the view that it would be useful if CMDs
are allowed to hawk AL because many people in the rural
areas cannot afford the cost of transportation.
Patent medicine sellers and health workers welcomed the
involvement of PMS and trained mothers for distributing
AL. This view was premised on the fact that PMS and com-
munity members were readily available compared to
health workers who are available only during official
hours and sometimes irregularly. PMS had some reserva-
tions about having to replenish their stock at the health
centres. The PMS would rather have drug stocks supplied
to them directly by the research team. They were also will-
ing to collect AL directly from the drug store at LG head-
quarters. The PMS were dissatisfied because they have had
to make repeated visits to health centres before they could
replenish their stock as the health workers were either not
at their posts or they have closed before CMDs get to the
health centre. One said: "some of us do not have time to go to
health centre especially when repeated visits have to be made".
Adherence to use of AL and occurrence of adverse event
The consensus during the FGDs and KIIs conducted post
intervention was that the people in the community used
AL very well. A community head said: "all children in my
community used it whenever they have a febrile illness. The
drug is very good and we will like the use extended to older
members of the community too".
Participants at FGDs comprising mostly young mothers
and fathers mentioned that they refer to the treatment
guideline to check for the dose of AL. Most of the FGD
participants mentioned that the mothers completed the
dose as instructed and this was corroborated by PMS and
health workers. However, some participants in the young
fathers' group mentioned that not all the mothers com-
pleted the dose of AL. One of the participants specificallyBMC Health Services Research 2008, 8:119 http://www.biomedcentral.com/1472-6963/8/119
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mentioned that his wife did not complete the dose in the
treatment of their child. When the issue of non-comple-
tion of AL dosage regimen was discussed further, the
fathers mentioned that some mothers stopped adminis-
tration of AL when the children are better. Some mothers
however disagreed and maintained that non-completion
of dosage regimen was an exception. One young woman
corroborating the reason given by the young fathers said:
"Some mothers may forget to complete the dose more so when
their children get better and are playing around".
Effectiveness and Safety of AL
All the participants mentioned that AL was very effective
and that they were satisfied with it. A PMS said: "The child
I administered the drug to got well and started playing soon
after commencement of the drug; the drug worked very well
beyond our expectations".
An old mother was particularly impressed with the rapid
improvement observed in the health of the ill children fol-
lowing administration of the AL. She said "whenever a
child is given the drug, the fever goes down quickly; child starts
to eat better and goes to play by the next day. It makes the chil-
dren strong again". A young father corroborated the asser-
tion and said: "the use of AL has led to a marked reduction in
time caregivers spend with a sick child because the children now
recover promptly and by the second day of use many of the sick
children were up and about".
Reports of adverse events following the use of AL were few
and far between. When asked about adverse events, one
woman noticed skin rash which she attributed to measles
infection. One PMS mentioned that he heard that a few of
the children in another community experienced mild skin
rash and passing of dark stool. However, these were not
serious and did not warrant an intervention.
Opinion about the implementation of the program
The consensus among all participants was that the pro-
gram went well and they perceived AL to be effective in the
treatment of malaria in children. An opinion leader said:
the project has been very useful to us as a community and our
children. Since the distribution of AL started, our children have
been receiving prompt and effective treatment for malaria. All
those treated with it got well with no adverse event. The drug is
good.
The health workers stated particularly that they pray that
the collaboration between the health centre and the other
CMDs continues.
Sustainability of the programme in the community
The issue of sustainability of the programme was a major
concern. Before winding up the study, meetings were held
with stake holders in the two health districts to deliberate
on possible ways of sustaining the program when the
research team must have withdrawn their services. A
number of suggestions were made at FGDs with caregivers
and KIIs with PMS and opinion leaders. All the sugges-
tions had the desire for sustainability of the programme in
common. Other key suggestions concerning sustainability
of the programme were:
▪ It was suggested that community leaders make it manda-
tory for community members to donate towards a fund
which is to be set up with the sole aim of providing trans-
port or transport fares to CMDs to collect drug from dis-
tribution point and providing incentives to the CMDs.
▪ The community should cooperate with the CMDs and
give them the required support. The participants men-
tioned that they will be ready to assist CMDs create aware-
ness.
▪ Some FGD participants mentioned that the Government
should adopt the programme and continue its implemen-
tation
▪ FGD participants were particularly insistent that CMDs
be remunerated as this will serve as motivation to con-
tinue their laudable service to the community. The remu-
neration was considered necessary because CMDs were
sacrificing time they should spend pursuing their personal
business on community service.
▪ Drugs should be made available at all times and should
be stored only by trained CMDs. It was also suggested that
drugs should be supplied directly to the PMS and 'mother
trainers' rather than going to health centre to replenish
stock. By so doing the community will be able to monitor
the distribution of the drug better, said a PMS.
▪ Research team or LG representative should pay supervi-
sory visits to the CMDs and communities.
Discussion
Home treatment of malaria using both orthodox medi-
cine and local herbal remedies is a common practice in
the study communities as well as many other rural com-
munities in Nigeria [13]. The low utilization of health
facilities as the first resort for malaria treatment in this
study corroborates reports from other African countries
[13,14]. Poor access to health care services and orthodox
drugs in rural areas as a result of their remote location and
poor socio-economic status is well recognized and consti-
tute an issue of inequality of access when compared to car-
egivers in the cities and urban area. This and the fact that
incorrect use of orthodox drugs is common underscore
the need to determine the feasibility of introducing a newBMC Health Services Research 2008, 8:119 http://www.biomedcentral.com/1472-6963/8/119
Page 10 of 13
(page number not for citation purposes)
antimalarial drug to the community especially rural and
to assess the community perception on its effectiveness.
Acceptability
The caregivers, CMDs and other members of the commu-
nities in which this study was conducted were very recep-
tive to the new drug (AL). The easy and convenient access
of community members to AL at reasonable cost initially
and latter at no cost and the observed rapid improvement
in the state of health of children treated with AL must have
contributed in no small measure to the acceptability by
the community. The fact that the AL distributed was pre-
packaged could also have contributed to the acceptability.
The acceptability of the blister pack is consistent with
results from a study in western Uganda [15] and rural
communities in Nigeria [13]. These studies found that car-
egivers and drug distributors preferred pre-packed drugs
over loosely packed tablets. The mentioned reasons for
this were safety, cleanliness and possibly facilitate correct
dosing. To further demonstrate the acceptability of AL is
the demand for extension of the intervention to the treat-
ment of malaria in adults and neighbouring communi-
ties. Community members were also willing to support
any measure that could ensure continued availability of
AL in their communities.
The superior efficacy of AL in the management of malaria
when compared to that of chloroquine which hitherto
was the antimalarial drug of choice has been well estab-
lished in clinical studies [8,16,17]. This study can only
mention that caregivers perceived AL to be effective but
cannot draw an objective conclusion on its effectiveness
because it is a small scale study based on purposive sam-
pling. However, the effectiveness of AL when distributed
at the community level by community members was
tested in an effectiveness study nested into this study (to
be reported in another paper).
Drug adherence and safety
Two main concerns in introducing ACT for use in HMM
context were adherence and safety of use. These were
borne out of the fact that the effectiveness and safety of AL
at the community level have not been evaluated in
Nigeria. In addition, the practice of HMM using orthodox
medicine has been shown to be largely incorrect in
Nigeria [2,13,18]. Some of the challenges identified in
past interventions carried out to improve HMM were also
identified in this study. These include failure of caregivers
to complete a full course of antimalarial drug including
AL [2,19,20], provision of financial motivation to CMDs
[21] and non-adherence of health workers to recommen-
dations on the use of AL [22].
In this study, adherence to correct dose of AL by caregivers
was attested to by participants at FGDs and KIIs. Although
this was subjective and from the perspective of the con-
sumers, there is a likelihood that this was the case as some
caregivers who used the drug were able to correctly recall
how the drug was used when asked by CMDs. This finding
is reassuring in view of potential to development of resist-
ance. However, the perception of some participants in this
study that some caregivers sometimes genuinely forget to
continue therapy once the ill child appears well or delib-
erately keep the remaining drug for latter use for another
child who falls ill should not be overlooked. Unknown to
caregivers, parasite clearance is not necessarily complete
before the patient improves. This practice if uncorrected
will encourage emergence of drug resistant parasites as
was witnessed with chloroquine. There is thus the need to
provide health education to the public and healthcare
workers alike emphasizing the need to always complete
the treatment regimen of not just AL but all ACTs.
Prompt treatment of malaria is an important factor in the
prognosis of the illness. It is encouraging that caregivers in
this study were said to have commenced treatment
promptly. This finding is similar to reports in other past
studies in the study environment [13,18]. This attitude is
favourable to implementation of home management of
malaria strategy which emphasizes prompt and correct
treatment. The malaria control unit of the Federal Minis-
try of Health, Nigeria should build upon this attribute of
the caregivers in the introduction of AL into the commu-
nity.
Throughout the study period, AL was perceived to be safe
with no report of significant adverse event by the commu-
nities. Although this finding is similar to reports of earlier
studies which reported mild adverse effect during clinical
trials [16,17] and among patients prescribed AL [22], it
cannot be used to draw conclusion on the safety of AL
because of the small scale nature of the study and the
qualitative design both of which constitute a limitation to
the generalizability of findings in this study. Despite this
seemingly good safety, the Federal Government and all
stake holders should put an effective pharmaco-vigilance
system in place when AL is deployed on a large scale.
Many interventions to improve adherence to correct dose
of antimalarial drug at home level have been demon-
strated to be effective [14,23-26] and this study is not an
exception. However, sustainability of the correct practice
is a major concern. This was addressed in this study by
providing a pictorial guide which was comprehensible to
the rural dwellers and served as a reference document
even after the researchers might have moved out of the
community. The availability of a trained resource person
within the community who they can contact in case of
doubt is another modality put in place to address the
problem. Although these modalities appeared to haveBMC Health Services Research 2008, 8:119 http://www.biomedcentral.com/1472-6963/8/119
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helped in ensuring adherence during intervention, there is
a need to assess their effectiveness at regular intervals after
the research team must have withdrawn from the commu-
nities.
Drug distribution
The drug distribution mechanism proposed by commu-
nity members varied at baseline. While many reasonably
favoured the use of the drug sellers (PMS and drug hawk-
ers) who were the main supplier of drugs in these areas,
there were misgivings by a handful of other participants
who would not want them involved because of distrust
and the perceived propensity of the drug sellers to maxi-
mize profit. However, this attitude was not demonstrated
by drug sellers during intervention in this study. On the
contrary, caregivers perceived drug sellers to be efficient
and accessible. There was no report of drug sellers charg-
ing illegal fees at any time during the study. The reported
good adherence by the drug sellers was probably
enhanced by the incentives by way of commission they
received on each pack of AL sold or distributed and com-
mitment to their community's health and development.
CMDs' performance
"Mother trainers" and PMS were perceived by caregivers
and other community members to be effective in this
study. Not much was said about the efficiency of the
health workers probably because they did not have to go
to the health facility and consequently had minimal inter-
action with them. However, drug sellers and "mother
trainers" who had to go to the health facility to replenish
their drug stock had a lot of reservations about their effec-
tiveness. They reported that health workers were often
absent from their duty post and were perceived to hoard
the study drug (AL). This attitude of the health workers
made the CMDs to prefer drug distributed to them directly
through other channels such as directly from the LGA
drug store and work under the supervision of community
leaders rather than health workers. The use of community
members to assess efficiency of health workers and vice
versa could be fraught with biases and prejudice existing
prior to the study. This not withstanding the negative atti-
tude of health workers if unchecked poses a major threat
to the deployment of AL at the community level in
Nigeria. Home management should not be seen as an
alternative to strengthening health systems. The Primary
Health care system needs to be strengthened and effective
monitoring put in place in order to ensure a sustainable
home management program. Following these a function-
ing linkage between the health facilities and the CMDs as
well as community leaders should be fostered. This link-
age is important to support HMM strategy because the
health care facilities are needed for supervisory role and
management of referred cases.
Sustainability of program and CMDs' performance
This study has demonstrated that community volunteers
and patent medicine sellers in the communities constitute
an effective channel for intervention which is similar to
findings by Marsh et al. [25]. The CMDs effective perform-
ance in this study was facilitated by the intervention in
form of training provided to them prior to assuming their
role as drug distributors and provision of incentives to
sustain behaviour change [27]. However, the sustainabil-
ity of their involvement and the regular supply of drug is
a major concern. One suggestion to sustaining the
involvement of the CMDs is maintenance of training and
supervision of their activities. However, where sellers lack
financial incentives to behave as they have been trained,
they tend to revert back to inappropriate practices [27].
Incentives which may not be sustainable contributed sig-
nificantly to the good performance of the CMDs during
this study. Four strategies have been advanced for improv-
ing the practices of retail pharmacies in developing coun-
tries: information, persuasion, incentives and coercion
[28]. The use of incentives to promote interventions and
change in behaviour remains a controversial issue
[21,29]. The outcome of this study suggests that if used
appropriately incentives can positively affect perform-
ance. In the study by Wasunna et al. [22], health care
workers at facility level demonstrated concern on the sus-
tainability of a program that provides expensive drugs free
to the people and the fear of drug being out-of-stock
resulted in non-adherence by the health workers to dis-
tribute drug as recommended. In an effort to ensure stocks
last, the health workers prescribed AL only to those they
perceived to have serious illness. Could the perception
that health workers hoarded drug in this study be related
to the perceive fear exhibited by health workers in Was-
suna et al. study but unspoken?
One way to address the issue of sustainability of commu-
nity based programme is community partnership and par-
ticipation strategy [30]. Efforts were made to address this
during the study. The engagement of the CMDs including
selected mothers was a demonstration of community par-
ticipation. However, more could not be done due to the
prevailing free drug policy by the government. A caveat to
the use of this strategy is that organizers of most commu-
nity based interventions seem to assume that because
malaria is a major cause of mortality community mem-
bers will volunteer their time free of charge to be trained,
or train others, to act as health educators and drug distrib-
utors [19]. However, this has been shown to be fraught
with problems. This was suggested in this study in which
the CMDs suggested the need to provide commission to
make up for the profit they would have made selling other
antimalarial drug and time used in carrying out the assign-BMC Health Services Research 2008, 8:119 http://www.biomedcentral.com/1472-6963/8/119
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ment despite the fact that it was made known to them that
it was a community volunteering work.
To scale up HMM using ACTs the government needs to
consider these challenges seriously and addressed them in
order to achieve successful implementation. In Nigeria,
the private sector, which consists of a great variety of pro-
viders including CMDs, is used by a wide cross-section of
the population [31]. Using the private sector to distribute
drugs is a good option to address the challenges faced by
consumers in the public sector. However, the practices of
medicine sellers in low-income countries have been dem-
onstrated to be fraught with many incorrect practices and
these constitute a major challenge to working with them.
Infringement of health-related regulation is extremely
common [32]. Most stores lack permit, stock unregistered
and/or expired drugs, stock prescription-only medicines,
sell drugs at inflated prices and the staff do not have the
minimum qualification required. The evidence is limited
as to which approaches work best for public-private col-
laboration to improve medicine sellers-based treatment.
Eliminating regulatory infringement is unlikely to be fea-
sible and could be undesirable if access to essential medi-
cines is reduced [32]. Alternatives include bringing official
drug regulation closer into line with locally legitimate
practices; greater use of positive incentives for providers;
and consumer involvement [32]. In this study as men-
tioned earlier, training and provision of incentives were
used and suggestions were made to the involvement of
community heads or opinion leaders in supervising and
monitoring drug distribution at the community level.
However, there have been many references to other
approaches such as social marketing, accreditation, fran-
chising and contracting [33]. Further research is necessary
to determine which of these strategies would be well
suited for use in the context of HMM in Nigeria.
Conclusion
The findings from this qualitative study showed that the
use of AL at home and community level is feasible and
acceptable to the members of the communities studied.
AL was perceived to be very effective and safe. The use of
CMDs made AL readily accessible and available in the
community and the CMDs were found to be effective.
These findings provide evidence to support scaling up
implementation of HMM with ACTs in Nigeria. However,
mechanisms to ensure long-term performance of CMDs,
sustain provision of free drug and strengthen the health
system should be developed.
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